Dose individualization and variable selection by using the Bayesian lasso in early phase dose finding trials

Yasuyuki Kakurai, Shuhei Kaneko, Chikuma Hamada and Akihiro Hirakawa

Journal of the Royal Statistical Society Series C, 2019, vol. 68, issue 2, 445-460

Abstract: Recommended phase 2 doses for some drugs may differ according to a patient's clinical or genetic characteristics. We develop a new method that determines the individualized optimal dose according to patterns of patient covariates and selects the covariates that are associated with efficacy and toxicity in early phase trials for evaluating multiple patient covariates of interest. To address the difficulty of high dimensional estimation of model parameters with a limited sample size, we propose the use of the Bayesian least absolute shrinkage and selection operator, which is a penalized regression approach. We demonstrate the potential utility of this proposed method through various simulation studies.

Date: 2019
References: Add references at CitEc
Citations:

Downloads: (external link)
https://doi.org/10.1111/rssc.12326

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bla:jorssc:v:68:y:2019:i:2:p:445-460

Ordering information: This journal article can be ordered from
http://ordering.onli ... 1111/(ISSN)1467-9876

Access Statistics for this article

Journal of the Royal Statistical Society Series C is currently edited by R. Chandler and P. W. F. Smith

More articles in Journal of the Royal Statistical Society Series C from Royal Statistical Society Contact information at EDIRC.
Bibliographic data for series maintained by Wiley Content Delivery ().